Leisure Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LACQ and buy or sell other stocks, ETFs, and their options commission-free!About LACQ
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees9
Employees9
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees9
Employees9
LACQ Key Statistics
Market cap46.09M
Market cap46.09M
Price-Earnings ratio-0.26
Price-Earnings ratio-0.26
Dividend yield—
Dividend yield—
Average volume92.18K
Average volume92.18K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.96
52 Week high$10.96
52 Week low$1.46
52 Week low$1.46
Stock Snapshot
The current Leisure Acquisition(LACQ) stock price is $14.49, with a market capitalization of 46.09M. The stock trades at a price-to-earnings (P/E) ratio of -0.26.
On 2025-12-04, Leisure Acquisition(LACQ) stock opened at —, reached a high of —, and a low of —.
The Leisure Acquisition(LACQ)'s current trading volume is 0, compared to an average daily volume of 92.18K.
During the past year, Leisure Acquisition(LACQ) stock moved between $1.46 at its lowest and $10.96 at its peak.
During the past year, Leisure Acquisition(LACQ) stock moved between $1.46 at its lowest and $10.96 at its peak.
People also own
Based on the portfolios of people who own LACQ. This list is generated using Robinhood data, and it’s not a recommendation.